As IL-36α levels were found to be remarkably increased in BS patients with history of genital or ocular involvement, subgroup analyses were conducted to assess whether IL-36α was able to also discriminate patients with these manifestations from those diagnosed with PsA. This evidence concerns the gene IL36A and Bloom syndrome.